Editor-in-Chief & Deputy Editor 2019-2021

 

Editor-in-Chief:

Nicolas LANTHIER

 

Deputy Editor:

Tim VANUYTSEL

 

 

Sponsors & Partners



Acta Gastroenterologica Belgica is supported by grants from its major sponsors

 

Acta Gastroenterologica Belgica is supported by grants

from its major sponsors

Dr Falk Pharma

 

 

 

 

 

 

Acta Gastro-Enterologica Belgica is published in

partnership with the following national societies


 

 

 

 

 

SRBGE

 

The paediatric liver transplantation program at the Université catholique de Louvain(1). (1) Presented at the Symposium “Liver transplantation and its alternatives in the third millennium”, in honour of professor Jean-Bernard Otte (Brussels,4 October 2The potential of glycomics as prognostic biomarkers in liver disease and liver transplantation

The pediatric liver transplant program at the Université Catholique de Louvain, Cliniques Saint-Luc, Brussels : Overall results in 444 children (1984-1997)

Price: €10,00








July-September Volume 62, fasc. 3

The pediatric liver transplant program at the Université Catholique de Louvain, Cliniques Saint-Luc, Brussels : Overall results in 444 children (1984-1997)

R. Reding, E Gennari, M. Janssen, J. Jamart, J. de Ville de Goyet, J. Lerut, E. Sokal, J.B. Otte. - Service de Chirurgie pédiatrique générale et abdominale, Cliniques universitaires Saint-Luc, Centre de Biostatistique et de Documentation médicale, Cliniques universitaires de Mont-Godinne; Present address: Paediatric Liver Unit (Birmingham, UK) Service de Chirurgie de l'Appareil digestif, Cliniques universitaires Saint-Luc.

Between 1984 and 1997, a total of 444 children (< 15 years) received an orthotopic liver transplant (OLT) at Saint-Luc University Clinics. Bihary atresia constituted the indication for OLT in 304 cases (68%). Median age (range) at OLT was 2.1 years (0.3-14.5). 177 children (40%) received a whole liver graft, 184 (41%) a reducedsize graft, 26 (6%) a split liver graft, whereas a living-related donor graft was used in 57 children (13%). Most grafts were ABO-identical or -compatible, in 395 cases (89%) and 40 (9%), respectively. Overall actuarial patient survivals at one and five years were 85% and 81%. The overall rltransplaintation rate was 19%. The results of @- and multivariate statistical analyses showed a significant impact of year of transplantation (learning curve effect), with a 15% improvement of patient survival between the 1984-7 and the 1995-7 periods (p < 0.002). Results differed according to the indications for OLT, the best survivals being recorded for familial cbolestasis, the worst for liver tumor (p = 0.004). Five year patient survival was significantly better after elective OLT (82%), when compared to highly urgent OLT (63%) (p < 0.001). Patient survivals were comparable in the children receiving primary cyclosporin-A niicroemulsion or tacro@us immunosuppression, which were significantly higher than in the historical group treated with cyclosporin-A. No impact of the age at OLT, type of graft and iscbemic time could be reported. In conclusion, this series illustrates the progressive improvements introduced in our pediatric liver transplant program between 1984 and 1997, including the technical variants allowing pediatric OLT using adult donors as well as the introduction of new immunosuppressive strategies. (Acta gasttoenterol. belg., 1"9, 62, 285-289).